Development of hepatitis C virus vaccine candidates

The studentship will focus on the design, development and pre-clinical testing of virus-like particle-based vaccines candidates for the prevention of hepatitis C virus (HCV) infection. The project will enable you to develop skills in reverse genetics and cloning, mammalian cell culture, pseudovirus and infectious virus work, protein expression and a variety of relevant immunological techniques, such as immunofluorescence, western blotting and ELISA. HCV affects around 200 million people globally and despite the recent advent of potent antiviral treatments, the need for an effective vaccine to prevent infection has not diminished. You will join a relatively small but thriving research group whose interests span emerging virus infections (for example Ebolavirus and Lassa fever) and blood borne viruses. We have established an international reputation for our work, especially in the study of antibody responses to HCV. Our expertise and study ethos will provide an encouraging environment for the PhD student to grow and develop their scientific and research skills.

To apply please email a full CV (to include the email addresses of two referees) and cover letter to: [Email Address Removed].

Closing date for applications: 20th October 2017
Interviews: Wil take place in the week commencing 6th November 2017
Anticipated start date: January 2nd 2018